Literature DB >> 31362044

Hyaluronan-CD44 axis orchestrates cancer stem cell functions.

Spyros S Skandalis1, Theodoros T Karalis2, Athanasios Chatzopoulos2, Nikos K Karamanos2.   

Abstract

The prominent role of CD44 in tumor cell signaling together with its establishment as a cancer stem cell (CSC) marker for various tumor entities imply a key role for CD44 in CSC functional properties. Hyaluronan, the main ligand of CD44, is a major constituent of CSC niche and, therefore, the hyaluronan-CD44 signaling axis is of functional importance in this special microenvironment. This review aims to provide recent advances in the importance of hyaluronan-CD44 interactions in the acquisition and maintenance of a CSC phenotype. Hyaluronan-CD44 axis has a substantial impact on stemness properties of CSCs and drug resistance through induction of EMT program, oxidative stress resistance, secretion of extracellular vesicles/exosomes and epigenetic control. Potential therapeutic approaches targeting CSCs based on the hyaluronan-CD44 axis are also presented.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD44; Cancer niche; Cancer stem cells (CSCs); Drug resistance; EMT; Exosomes; Hyaluronan

Year:  2019        PMID: 31362044     DOI: 10.1016/j.cellsig.2019.109377

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  32 in total

Review 1.  Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance.

Authors:  Debanwita Roy Burman; Shalini Das; Rahul Bhattacharya; Chandrima Das
Journal:  Mol Biol Rep       Date:  2021-01-05       Impact factor: 2.316

Review 2.  Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy: Thematic Review Series: Biology of Lipid Rafts.

Authors:  Faustino Mollinedo; Consuelo Gajate
Journal:  J Lipid Res       Date:  2020-11-07       Impact factor: 5.922

Review 3.  Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy.

Authors:  Faustino Mollinedo; Consuelo Gajate
Journal:  J Lipid Res       Date:  2020-01-27       Impact factor: 5.922

4.  Modulating microenvironments for treating glioblastoma.

Authors:  LaDeidra Monet Roberts; Jennifer Munson
Journal:  Curr Tissue Microenviron Rep       Date:  2020-08-13

5.  Expression of CD44 Isoforms in Tumor Samples and Cell Lines of Human Colorectal Cancer.

Authors:  V O Novosad; I S Polikanova; E A Tonevitsky; D V Maltseva
Journal:  Bull Exp Biol Med       Date:  2022-05-27       Impact factor: 0.804

6.  A new era: tumor microenvironment in chemoresistance of pancreatic cancer.

Authors:  Xueping Zhao; Zongze Li; Zongting Gu
Journal:  J Cancer Sci Clin Ther       Date:  2022-02-15

Review 7.  The emerging roles of circular RNAs in vessel co-option and vasculogenic mimicry: clinical insights for anti-angiogenic therapy in cancers.

Authors:  Ying Shao; Bingjian Lu
Journal:  Cancer Metastasis Rev       Date:  2021-10-18       Impact factor: 9.264

8.  Cancer Cell CD44 Mediates Macrophage/Monocyte-Driven Regulation of Head and Neck Cancer Stem Cells.

Authors:  Karina E Gomez; FangLong Wu; Stephen B Keysar; J Jason Morton; Bettina Miller; Tugs-Saikhan Chimed; Phuong N Le; Cera Nieto; Farshad N Chowdhury; Anit Tyagi; Traci R Lyons; Christian D Young; Hongmei Zhou; Hilary L Somerset; Xiao-Jing Wang; Antonio Jimeno
Journal:  Cancer Res       Date:  2020-08-14       Impact factor: 12.701

9.  The ECM Modulator ITIH5 Affects Cell Adhesion, Motility and Chemotherapeutic Response of Basal/Squamous-Like (BASQ) Bladder Cancer Cells.

Authors:  Michael Rose; Erik Noetzel; Jennifer Kistermann; Julian Eschenbruch; Sandra Rushrush; Lin Gan; Ruth Knüchel; Nadine T Gaisa; Edgar Dahl
Journal:  Cells       Date:  2021-04-28       Impact factor: 6.600

Review 10.  Molecular Crosstalk between the Hepatitis C Virus and the Extracellular Matrix in Liver Fibrogenesis and Early Carcinogenesis.

Authors:  Emma Reungoat; Boyan Grigorov; Fabien Zoulim; Eve-Isabelle Pécheur
Journal:  Cancers (Basel)       Date:  2021-05-09       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.